These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. Tashkin DP, Rennard SI, Martin P, Ramachandran S, Martin UJ, Silkoff PE, Goldman M. Drugs; 2008; 68(14):1975-2000. PubMed ID: 18778120 [Abstract] [Full Text] [Related]
4. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. Partridge MR, Schuermann W, Beckman O, Persson T, Polanowski T. Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176 [Abstract] [Full Text] [Related]
5. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B, Dhembare P, Jantikar A, Mahadik P, Gokhale P, Gogtay JA, Salvi SS. Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763 [Abstract] [Full Text] [Related]
6. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. Kaiser H, Parasuraman B, Boggs R, Miller CJ, Leidy NK, O'Dowd L. Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453 [Abstract] [Full Text] [Related]
9. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. Lindberg A, Szalai Z, Pullerits T, Radeczky E. Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063 [Abstract] [Full Text] [Related]
13. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W, Levine B, Andriano K, Lavecchia C, Yegen U. Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475 [Abstract] [Full Text] [Related]
14. Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results. Fukuchi Y, Samoro R, Fassakhov R, Taniguchi H, Ekelund J, Carlsson LG, Ichinose M. Respirology; 2013 Jul; 18(5):866-73. PubMed ID: 23551359 [Abstract] [Full Text] [Related]
19. Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation. Santus P, Centanni S, Verga M, Di Marco F, Matera MG, Cazzola M. Respir Med; 2006 Jul; 100(7):1277-81. PubMed ID: 16337781 [Abstract] [Full Text] [Related]